Labetalol: Difference between revisions

(Add dynamic SMW Indications by Condition table (auto-populated from disease pages via MedicationDose template))
(Switch SMW query from broadtable to table format for better layout with TOC)
 
(One intermediate revision by the same user not shown)
Line 62: Line 62:
  |?Has Route=Route
  |?Has Route=Route
  |?Has Population=Population
  |?Has Population=Population
  |format=broadtable
  |format=table
  |headers=plain
  |headers=plain
  |link=subject
  |mainlabel=-
  |sort=Has Indication
  |sort=Has Indication
  |limit=50
  |limit=50

Latest revision as of 21:55, 20 March 2026

General

Adult Dosing

  • Bolus dosing
    • 20mg IV followed by 40-80mg q10min up to total of 300mg
  • Infusion dosing
    • 0.5-2mg/min

Intracranial hemorrhage

  • Start with labetalol 20mg over 1-2 minutes
    • Then, 20mg q3-5 mins until target blood pressure is achieved
    • Then, start an infusion of 1-8mg/min

Pediatric Dosing

Special Populations

  • Pregnancy Rating: C
  • Lactation: Compatible with breastfeeding
  • Renal Dosing
    • Adult
      • No renal dosing adjustments necessary. Drug not removed with hemodialysis
    • Pediatric
      • No renal dosing adjustments necessary. Drug not removed with hemodialysis
  • Hepatic Dosing
    • Adult
      • May need reduced dosing given decreased metabolism and increased oral bioavailability with hepatic impairment however no specific dosing adjustments in manufacturer labeling. Use caution.
    • Pediatric
      • May need reduced dosing given decreased metabolism and increased oral bioavailability with hepatic impairment however no specific dosing adjustments in manufacturer labeling. Use caution.

Indications

  • hypertension in setting of myocardial ischemia
  • hypertension in setting of neurologic injury
  • hypertension in setting of preeclampsia/eclampsia

Contraindications

  • Allergy to class/drug

Adverse Reactions

  • Orthostatic hypotension

Pharmacology

  • Half-life: 5-8hrs
  • Metabolism: Hepatic via conjugation
  • Excretion: Renal 55-60%
  • Mechanism of Action:
    • Class II - Nonselective β-blocker
    • α1-blocker
  • Onset of action = 2-5min (IV)
  • Duration of action = 2-4hr (IV)


Indications by Condition

The following table is automatically generated from disease/condition pages across WikEM.

IndicationDoseContextRoutePopulation
Hypertensive emergency20 mg IV bolus, double q10 min (max 300 mg) or 0.5-2 mg/min drip1st line antihypertensiveIVAdult
Intracranial hemorrhage (main)20 mg IV bolus, repeat q3-5 min; then 1-8 mg/min dripBP control in ICHIVAdult
Nontraumatic thoracic aortic dissection20mg bolus, then 40-80mg q10min (max 300mg) or 1-2mg/min dripHeart rate and blood pressure controlIVAdult
Stroke (main)10-20 mg IV push, may repeat x1BP control in acute strokeIVAdult
Traumatic intracerebral hemorrhage20 mg IV bolus, repeat q3-5 min; then 1-8 mg/min dripBP control in ICHIVAdult

See Also

References


Labetalol: Drug information. UpToDate. www.uptodate.com. Accessed April 2, 2019.